- Trials with a EudraCT protocol (240)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (5)
240 result(s) found for: Histopathology.
Displaying page 1 of 12.
EudraCT Number: 2021-000148-23 | Sponsor Protocol Number: FAPI-PET-Trial | Start Date*: 2021-06-30 |
Sponsor Name:University Hospital Essen | ||
Full Title: 68Ga-FAPI-46 PET for imaging of FAP expressing cancer: A single-center prospective interventional single-arm clinical Trial | ||
Medical condition: Patients receiving 68Ga-FAPI-46 PET both at initial diagnosis and restaging before treatment decisions | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-002513-19 | Sponsor Protocol Number: 2011/609-31/1 | Start Date*: 2012-10-29 |
Sponsor Name:Karolinska University Hospital Solna | ||
Full Title: 68Ga-DOTATOC-PET/CT for diagnosis of neuroendocrina tumours | ||
Medical condition: Neuroendocrine tumour | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003614-40 | Sponsor Protocol Number: SVB800_001 | Start Date*: 2019-06-06 | |||||||||||
Sponsor Name:Bracco Imaging Spa | |||||||||||||
Full Title: MOLECULAR FLUORESCENCE-GUIDED SURGERY USING BEVA800 FOR THE ASSESSMENT OF TUMOR MARGINS DURING BREAST CONSERVING SURGERY OF PATIENTS WITH PRIMARY BREAST CANCER (MARGIN-II) | |||||||||||||
Medical condition: Primary breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000370-30 | Sponsor Protocol Number: 20150706 | Start Date*: 2015-11-26 |
Sponsor Name:Norrlands University Hospital | ||
Full Title: Diagnosis and follow up of neuroendocrine tumours with 68Ga-DotaToc PET/CT | ||
Medical condition: Neuroendocrine tumors | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001586-87 | Sponsor Protocol Number: RSLV-132-04 | Start Date*: 2016-09-29 |
Sponsor Name:Resolve Therapeutics, LLC | ||
Full Title: A Phase 2, Double Blind, Placebo Controlled Study of RSLV-132 in Subjects with Primary Sjogren’s Syndrome | ||
Medical condition: Primary Sjogrens Syndrome | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-004269-14 | Sponsor Protocol Number: HP002-001 | Start Date*: 2018-05-07 |
Sponsor Name:Hamlet Pharma AB | ||
Full Title: A Randomized Placebo controlled Phase I/II Study Evaluating the Safety and Efficacy of Alpha1H in adult patients with non-muscle invasive bladder cancer awaiting transurethral surgery | ||
Medical condition: Non-muscle invasive bladder cancer awaiting transurethral surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-006074-10 | Sponsor Protocol Number: MEE103219 | Start Date*: 2006-06-15 |
Sponsor Name:GlaxoSmithKline Research & Development Ltd. | ||
Full Title: A randomized, double-blind, parallel group clinical trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of intravenous mepolizumab (SB240563) (0.55mg/kg, 2.5mg/kg or 10mg/k... | ||
Medical condition: Eosinophilic oesophagitis | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-000112-21 | Sponsor Protocol Number: MESI-STRAT-WOO | Start Date*: 2018-09-03 | |||||||||||
Sponsor Name:Ruprecht-Karls-Universität Heidelberg, Medizinische Fakultät, vertreten durch das Universitätsklinikum Heidelberg | |||||||||||||
Full Title: Prospective Window of opportunity trial 3 weeks neoadjuvant Anastrozole in Postmenopausal Women with Estrogen receptor positive (ER+) Breast Cancer | |||||||||||||
Medical condition: (ER+) Breast Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001387-28 | Sponsor Protocol Number: NL73559.091.20 | Start Date*: 2020-06-22 | ||||||||||||||||
Sponsor Name:Radboud University Medical Center | ||||||||||||||||||
Full Title: 18F-PSMA-1007 PET to detect primary prostate cancer: a comparative study with mpMRI and correlation to histopathology. | ||||||||||||||||||
Medical condition: 75 patients with the suspicion on PCa (elevated PSA and/or abnormal digital rectal exam) will receive a PSMA-PET following mpMRI. 25 patients with PIRADS 1-2 (probably benign disease), 25 patients ... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003960-22 | Sponsor Protocol Number: WOO2 | Start Date*: 2021-03-15 | |||||||||||
Sponsor Name:Medical University of Innsbruck | |||||||||||||
Full Title: Prospective Window of opportunity trial of 3 weeks neoadjuvant Anastrozole in Postmenopausal Women with Estrogen receptor positive (ER+) Breast Cancer | |||||||||||||
Medical condition: (ER+) Breast Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004310-18 | Sponsor Protocol Number: SPL-01-001 | Start Date*: 2019-10-07 | |||||||||||
Sponsor Name:Saving Patients' Lives Medical B.V. | |||||||||||||
Full Title: A confirmatory, prospective, open-label, single-arm, reader-blinded multi-centre phase 3 study to assess the diagnostic accuracy of Ferumoxtran-10-enhanced Magnetic Resonance Imaging (MRI) and unen... | |||||||||||||
Medical condition: newly-diagnosed prostate cancer (PCA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Ongoing) NL (Completed) BE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003768-30 | Sponsor Protocol Number: IEO906 | Start Date*: 2019-11-12 | |||||||||||
Sponsor Name:ISTITUTO EUROPEO DI ONCOLOGIA | |||||||||||||
Full Title: Neoadjuvant peptide receptor radionuclide therapy (PRRT) with 90Y-DOTATOC in pancreatic neuroendocrine tumors | |||||||||||||
Medical condition: Pancreatic neuroendocrine tumors | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001748-23 | Sponsor Protocol Number: SGM-LARRC | Start Date*: 2019-08-07 | ||||||||||||||||
Sponsor Name:Leiden University Medical Center | ||||||||||||||||||
Full Title: Multicenter, open-label, controlled, parallel arms clinical study on the performance of SGM-101, a fluorochrome-labeled anti-carcino-embryonic antigen (CEA) monoclonal antibody, for locally advance... | ||||||||||||||||||
Medical condition: Locally advanced rectal cancer Recurrent rectal cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002299-41 | Sponsor Protocol Number: KY1005-CT02 | Start Date*: 2019-01-24 | |||||||||||
Sponsor Name:Kymab Limited | |||||||||||||
Full Title: A Phase IIa, Randomised, Double Blind, Placebo Controlled, Parallel Group, Multicentre Study of an Anti OX40L Monoclonal Antibody (KY1005) in Moderate to Severe Atopic Dermatitis | |||||||||||||
Medical condition: Atopic dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002609-31 | Sponsor Protocol Number: ISO-44-013 | Start Date*: 2012-01-27 | |||||||||||
Sponsor Name:Guerbet | |||||||||||||
Full Title: Diagnostic contribution of XENETIX® CT PERFUSION in pre-therapeutical assessment of hepatocellular carcinoma. | |||||||||||||
Medical condition: Subjects diagnosed for HCC and planned for surgery (tumorectomy, sectionectomy, segmentectomy, lobectomy or transplantation). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-006141-19 | Sponsor Protocol Number: UMCG-RR#202000930 | Start Date*: 2021-05-21 | |||||||||||
Sponsor Name:University Medical Center Groningen | |||||||||||||
Full Title: Fluorescence guided surgery for intra-operative detection of meningioma using Bevacizumab-IRDye800CW | |||||||||||||
Medical condition: meningioma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004217-14 | Sponsor Protocol Number: P21.128 | Start Date*: 2022-11-09 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: FLUOPANC-trial - Intraoperative near-infrared fluorescence imaging in pancreatic- and extrahepatic bile duct tumors using cRGD-ZW800-1 and dedicated imaging systems: A phase II feasibility, dose-ra... | ||
Medical condition: Pancreatic cancer (pancreatic carcinoma) Extrahepatic bile duct cancer (cholangiocarcinoma) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-002779-12 | Sponsor Protocol Number: 10968 | Start Date*: 2023-02-06 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Real-time margin assessment in head and neck cancer – enhancing specificity by combining fresh frozen sectioning with targeted fluorescence imaging The LIGHTNING study | ||
Medical condition: Head and neck cancer for which surgical excision has been determined by the multidisciplinary tumor board | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003884-12 | Sponsor Protocol Number: EXTRAStudy | Start Date*: 2015-12-22 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PAPA GIOVANNI XXIII | |||||||||||||
Full Title: A pilot, prospective, randomized, open-label, blinded endpoint (PROBE) histopathology trial to assess the effects of ACE- inhibition therapy on glomerular proliferative lesions in patients with ext... | |||||||||||||
Medical condition: Extracapillary glomerulonephritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003382-18 | Sponsor Protocol Number: BED-PSMA-302 | Start Date*: 2020-05-25 | |||||||||||
Sponsor Name:Blue Earth Diagnostics Ireland Ltd. | |||||||||||||
Full Title: A prospective, Phase 3, multi-center, single-arm, imaging study investigating the safety and diagnostic performance of rhPSMA-7.3 (18F) PET ligand in men with suspected prostate cancer recurrence b... | |||||||||||||
Medical condition: Prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FI (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
